0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Professor Nicholas Tonks' laboratory achieved a significant breakthrough that revolves around a groundbreaking antibody that has the potential to suppress a critical enzyme associated with the spread of certain breast tumours.
Share this article
If you liked this article share it with your friends.they will thank you later